Prevalence and associations of the metabolic syndrome among patients prescribed clozapine.

Colm Mcdonald; Brendan Dineen

doi:10.1007/s11845-008-0156-9

Prevalence and associations of the metabolic syndrome among patients prescribed clozapine.

Colm Mcdonald
, Brendan Dineen

University of Galway
Galway University Hospital

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

28 Citations (Scopus)

Abstract

There is increasing concern that the use of second-generation antipsychotic medications in schizophrenia is associated with the development of metabolic syndrome.

Original language	English (Ireland)
Pages (from-to)	205-210
Number of pages	6
Journal	Ir J Med Sci
Volume	177
Issue number	3
DOIs	https://doi.org/10.1007/s11845-008-0156-9
Publication status	Published - 1 Sept 2008

Keywords

Atypical antipsychotics
Clozapine
Metabolic syndrome
Physical illness

Access to Document

10.1007/s11845-008-0156-9

Cite this

@article{4a497f8d430c4ed68ae9b0e75fc8de2f,

title = "Prevalence and associations of the metabolic syndrome among patients prescribed clozapine.",

abstract = "There is increasing concern that the use of second-generation antipsychotic medications in schizophrenia is associated with the development of metabolic syndrome.",

keywords = "Atypical antipsychotics, Clozapine, Metabolic syndrome, Physical illness",

author = "Colm Mcdonald and Brendan Dineen",

year = "2008",

month = sep,

day = "1",

doi = "10.1007/s11845-008-0156-9",

language = "English (Ireland)",

volume = "177",

pages = "205--210",

journal = "Ir J Med Sci",

number = "3",

}

TY - JOUR

T1 - Prevalence and associations of the metabolic syndrome among patients prescribed clozapine.

AU - Mcdonald, Colm

AU - Dineen, Brendan

PY - 2008/9/1

Y1 - 2008/9/1

N2 - There is increasing concern that the use of second-generation antipsychotic medications in schizophrenia is associated with the development of metabolic syndrome.

AB - There is increasing concern that the use of second-generation antipsychotic medications in schizophrenia is associated with the development of metabolic syndrome.

KW - Atypical antipsychotics

KW - Clozapine

KW - Metabolic syndrome

KW - Physical illness

UR - https://www.scopus.com/pages/publications/48549090435

U2 - 10.1007/s11845-008-0156-9

DO - 10.1007/s11845-008-0156-9

M3 - Article

VL - 177

SP - 205

EP - 210

JO - Ir J Med Sci

JF - Ir J Med Sci

IS - 3

ER -

Prevalence and associations of the metabolic syndrome among patients prescribed clozapine.

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this